The Efficacy of Dexamethasone Versus N‐Acetylcysteine in Prevention of Post‐Embolization Syndrome in Hepatocellular Carcinoma Patients: A Multicenter Randomized, Double‐Blind, Double‐Dummy, Non‐Inferiority Trial
Padungkeat Karasin, Kittithat Tantitanawat, Chanchai Charonpongsuntorn, Anuchit Suksamai, Sakkarin Chirapongsathorn. The Efficacy of Dexamethasone Versus N‐Acetylcysteine in Prevention of Post‐Embolization Syndrome in Hepatocellular Carcinoma Patients: A Multicenter Randomized, Double‐Blind, Double‐Dummy, Non‐Inferiority Trial. // Asia-Pacific Journal of Clinical Oncology. – 2026. – DOI: 10.1111/ajco.70127. – URL: https://onlinelibrary.wiley.com/doi/10.1111/ajco.70127?af=R
Padungkeat Karasin, Kittithat Tantitanawat, Chanchai Charonpongsuntorn, Anuchit Suksamai, & Sakkarin Chirapongsathorn (2026). The Efficacy of Dexamethasone Versus N‐Acetylcysteine in Prevention of Post‐Embolization Syndrome in Hepatocellular Carcinoma Patients: A Multicenter Randomized, Double‐Blind, Double‐Dummy, Non‐Inferiority Trial. Asia-Pacific Journal of Clinical Oncology. https://doi.org/10.1111/ajco.70127
Padungkeat Karasin, et al. “The Efficacy of Dexamethasone Versus N‐Acetylcysteine in Prevention of Post‐Embolization Syndrome in Hepatocellular Carcinoma Patients: A Multicenter Randomized, Double‐Blind, Double‐Dummy, Non‐Inferiority Trial.” Asia-Pacific Journal of Clinical Oncology, 2026. doi:10.1111/ajco.70127.
@article{Karasin2026,
title = {The Efficacy of Dexamethasone Versus N‐Acetylcysteine in Prevention of Post‐Embolization Syndrome in Hepatocellular Carcinoma Patients: A Multicenter Randomized, Double‐Blind, Double‐Dummy, Non‐Inferiority Trial},
author = {Karasin, Padungkeat and Tantitanawat, Kittithat and Charonpongsuntorn, Chanchai and Suksamai, Anuchit and Chirapongsathorn, Sakkarin},
journal = {Asia-Pacific Journal of Clinical Oncology},
year = {2026},
doi = {10.1111/ajco.70127},
url = {https://onlinelibrary.wiley.com/doi/10.1111/ajco.70127?af=R}
}
Nature Reviews Cancer, Published online: 19 November 2026; doi:10.1038/s41568-026-01001-2 In this Journal Club, Chien-Han Kao and Ruey-Hwa Chen discuss a study showing that tumours use both de novo purine biosynthesis and purine salvage...
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01779-2 Targeting SMYD3 in cancer-associated fibroblasts relieves immune suppression and improves anti-PD-L1 response in HPV-negative HNSCC
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01786-3 Postoperative timing effects on AI-based resection-cavity segmentation in glioma: multi-site evaluation and relevance assessment